Medincell Aktie
16,30EUR | -0,39EUR | -2,34% |
WKN DE: A2N6VA / ISIN: FR0004065605
Personal
2021 | 2022 | 2023 | 2024 | 2025 | |
---|---|---|---|---|---|
Personal am Ende des Jahres | 148 | 149 | 143 | 134 | 140 |
Umsatz pro Mitarbeiter in Mio. EUR | 0,06 | 0,03 | 0,07 | 0,07 | 0,18 |
Bilanz (in Mio. EUR) - Aktiva
2021 | 2022 | 2023 | 2024 | 2025 | |
---|---|---|---|---|---|
Summe Umlaufvermögen | 56 | 34 | 20 | 27 | 81 |
Summe Anlagevermögen | 7 | 10 | 10 | 10 | 0 |
Summe Aktiva | 64 | 44 | 29 | 37 | 0 |
Bilanz (in Mio. EUR) - Passiva
2021 | 2022 | 2023 | 2024 | 2025 | |
---|---|---|---|---|---|
Summe Fremdkapital | 55 | 58 | 72 | 78 | 107 |
Summe Eigenkapital | 9 | -13 | -42 | -41 | -16 |
Summe Passiva | 64 | 44 | 29 | 37 | 0 |
Adresse
3, rue des Frères Lumière, 34830 Jacou | |
Internet | http://www.medincell.com |
Management
Adolfo Lopez-Noriega
Head-Research & Development |
Christophe Douat
Chief Executive Officer |
Christophe Roberge
Technical Director |
Elisabeth Kogan
Member-Supervisory Board |
Franck Pouzache
Chief People Officer |
Grace Kim
Investors Relations Contact |
Julie Alimi
Head-Legal |
Pascal Touchon
Director |
Philippe Guy
Chairman-Supervisory Board |
Richard Malamut
Chief Medical Officer |
Sabri Markabi
Vice Chairman-Supervisory Board |
Stéphane Postic
Chief Financial Officer |
Sébastien Enault
Chief Business Officer |
Sébastien Magnat
Head-Operations |
Tone Kvåle
Member-Supervisory Board |
Virginie Lleu
Member-Supervisory Board |